Israel Englander’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75,100
Closed -$575K 6319
2026
Q1
$575K Sell
75,100
-74,900
-50% -$573K ﹤0.01% 4694
2025
Q4
$1.46M Sell
150,000
-150,000
-50% -$1.28M ﹤0.01% 4209
2025
Q3
$1.26M Buy
300,000
+225,000
+300% +$1.44M ﹤0.01% 4445
2025
Q2
$697K Buy
+75,000
New +$654K ﹤0.01% 4671

Other funds holding REPL

Israel Englander's REPL Position: Q2 2026 in Review

Israel Englander increased its Replimune Group (REPL) stake by 173% in Q2 2026, buying an estimated $3.19M and bringing the position to 821,958 shares worth $9.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Israel Englander first reported a position in REPL in Q4 2019 and has held it in 26 quarters since. The position peaked at $28.1M in Q2 2024. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Israel Englander held 821,958 shares of Replimune Group worth $9.1M as of Q2 2026.
  • Israel Englander bought 521,125 Replimune Group shares in Q2 2026, an estimated $3.19M.
  • Replimune Group made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2372 holding.
  • Israel Englander first reported a position in Replimune Group in Q4 2019 and has held it in 26 quarters since.
  • Israel Englander's Replimune Group position peaked at $28.1M in Q2 2024.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.